Role of nucleophosmin in embryonic development and tumorigenesis
A role for nucleophosmin Nucleophosmin is an oestrogen-regulated nucleolar protein that has been implicated in a number of cancers including myelodysplastic syndromes (MDS), a group of diseases characterized by overproduction of blood cells in the bone marrow. Now a role for nucleophosmin has been i...
Gespeichert in:
Veröffentlicht in: | Nature (London) 2005-09, Vol.437 (7055), p.147-153 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A role for nucleophosmin
Nucleophosmin is an oestrogen-regulated nucleolar protein that has been implicated in a number of cancers including myelodysplastic syndromes (MDS), a group of diseases characterized by overproduction of blood cells in the bone marrow. Now a role for nucleophosmin has been identified in normal cells: it is essential for normal embryonic development and, specifically, for the control of centrosome duplication and genomic stability. Loss of the
Npm1
gene in mice produces features similar to those seen in MDS patients.
Nucleophosmin (also known as NPM, B23, NO38) is a nucleolar protein directly implicated in cancer pathogenesis, as the
NPM1
gene is found mutated and rearranged in a number of haematological disorders
1
,
2
,
3
,
4
,
5
. Furthermore, the region of chromosome 5 to which
NPM1
maps is deleted in a proportion of
de novo
human myelodysplastic syndromes (MDS)
6
,
7
,
8
,
9
, and loss of chromosome 5 is extremely frequent in therapy-related MDS
9
,
10
. NPM is a multifunctional protein
11
,
12
,
13
,
14
,
15
, and its role in oncogenesis is controversial as NPM has been attributed with both oncogenic and tumour suppressive functions
16
,
17
,
18
,
19
. To study the function of Npm
in vivo
, we generated a hypomorphic
Npm1
mutant series (
Npm1
+/-
<
Npm1
hy/hy
<
Npm1
-/-
) in mouse. Here we report that Npm is essential for embryonic development and the maintenance of genomic stability.
Npm1
-/-
and
Npm1
hy/hy
mutants have aberrant organogenesis and die between embryonic day E11.5 and E16.5 owing to severe anaemia resulting from defects in primitive haematopoiesis. We show that
Npm1
inactivation leads to unrestricted centrosome duplication and genomic instability. We demonstrate that Npm is haploinsufficient in the control of genetic stability and that
Npm1
heterozygosity accelerates oncogenesis both
in vitro
and
in vivo
. Notably,
Npm1
+/-
mice develop a haematological syndrome with features of human MDS. Our findings uncover an essential developmental role for Npm and implicate its functional loss in tumorigenesis and MDS pathogenesis. |
---|---|
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/nature03915 |